Stem cell shot aims to tame multiple sclerosis
NCT ID NCT04956744
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage trial tests a single intravenous dose of IMS001, a stem cell product made from human embryonic cells, in 30 adults with multiple sclerosis who have not responded well to standard treatments. The main goal is to see if the treatment is safe and tolerable, while also looking for any signs that it might help control the disease.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
IMS001 (stem cells from human embryos)
What this could lead to
If it works, this could point toward a new treatment option for multiple sclerosis patients who haven't responded to standard therapies.
What could go wrong
This is a very early Phase 1 trial with only 30 people, so it's mainly checking safety. The stem cells may not improve symptoms, and there could be side effects like allergic reactions or lab abnormalities.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Rocky Mountain MS Clinic
Salt Lake City, Utah, 84103, United States
-
Shepherd Center
Atlanta, Georgia, 30309, United States
-
UMass Memorial Medical Center
Worcester, Massachusetts, 01605, United States